Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

State of the Science of Neural Systems in Late-Life Depression: Impact on Clinical Presentation and Treatment Outcome.

Manning KJ, Steffens DC.

J Am Geriatr Soc. 2018 Apr;66 Suppl 1:S17-S23. doi: 10.1111/jgs.15353.

PMID:
29659005
2.

Arterial stiffness is associated with depression in middle-aged men - the Maastricht Study.

Onete V, Henry RM, Sep SJS, Koster A, van der Kallen CJ, Dagnelie PC, Schaper N, Köhler S, Reesink K, Stehouwer CDA, Schram MT.

J Psychiatry Neurosci. 2018 Mar;43(2):111-119.

3.

Plasma sphingolipids and depressive symptoms in coronary artery disease.

Dinoff A, Saleem M, Herrmann N, Mielke MM, Oh PI, Venkata SLV, Haughey NJ, Lanctôt KL.

Brain Behav. 2017 Sep 26;7(11):e00836. doi: 10.1002/brb3.836. eCollection 2017 Nov.

4.

Cerebral blood flow changes in remitted early- and late-onset depression patients.

Liao W, Wang Z, Zhang X, Shu H, Wang Z, Liu D, Zhang Z.

Oncotarget. 2017 Jul 12;8(44):76214-76222. doi: 10.18632/oncotarget.19185. eCollection 2017 Sep 29.

5.

Post-Stroke Depression: Impact of Lesion Location and Methodological Limitations-A Topical Review.

Nickel A, Thomalla G.

Front Neurol. 2017 Sep 21;8:498. doi: 10.3389/fneur.2017.00498. eCollection 2017. Review.

6.

Brain Tissue Pulsatility is Increased in Midlife Depression: a Comparative Study Using Ultrasound Tissue Pulsatility Imaging.

Desmidt T, Brizard B, Dujardin PA, Ternifi R, Réméniéras JP, Patat F, Andersson F, Cottier JP, Vierron E, Gissot V, Kim K, Aizenstein H, El-Hage W, Camus V.

Neuropsychopharmacology. 2017 Dec;42(13):2575-2582. doi: 10.1038/npp.2017.113. Epub 2017 Jun 6.

PMID:
28585568
7.

Association of Microvascular Dysfunction With Late-Life Depression: A Systematic Review and Meta-analysis.

van Agtmaal MJM, Houben AJHM, Pouwer F, Stehouwer CDA, Schram MT.

JAMA Psychiatry. 2017 Jul 1;74(7):729-739. doi: 10.1001/jamapsychiatry.2017.0984. Review.

PMID:
28564681
8.

Neuropsychiatric Symptoms in Mild Cognitive Impairment.

Gallagher D, Fischer CE, Iaboni A.

Can J Psychiatry. 2017 Mar;62(3):161-169. doi: 10.1177/0706743716648296. Review.

10.

Vascular depression consensus report - a critical update.

Aizenstein HJ, Baskys A, Boldrini M, Butters MA, Diniz BS, Jaiswal MK, Jellinger KA, Kruglov LS, Meshandin IA, Mijajlovic MD, Niklewski G, Pospos S, Raju K, Richter K, Steffens DC, Taylor WD, Tene O.

BMC Med. 2016 Nov 3;14(1):161.

11.

Association of Cerebral Amyloidosis, Blood Pressure, and Neuronal Injury with Late-Life Onset Depression.

Byun MS, Choe YM, Sohn BK, Yi D, Han JY, Park J, Choi HJ, Baek H, Lee JH, Kim HJ, Kim YK, Yoon EJ, Sohn CH, Woo JI, Lee DY.

Front Aging Neurosci. 2016 Oct 13;8:236. eCollection 2016.

12.

Carotid Stiffness: A Novel Cerebrovascular Disease Risk Factor.

van Sloten TT, Stehouwer CD.

Pulse (Basel). 2016 Jul;4(1):24-7. doi: 10.1159/000445354. Epub 2016 Apr 15. Review.

13.

Obstructive Sleep Apnea is Linked to Depression and Cognitive Impairment: Evidence and Potential Mechanisms.

Kerner NA, Roose SP.

Am J Geriatr Psychiatry. 2016 Jun;24(6):496-508. doi: 10.1016/j.jagp.2016.01.134. Epub 2016 Apr 29. Review.

14.

Strategies to improve anxiety and depression in patients with COPD: a mental health perspective.

Tselebis A, Pachi A, Ilias I, Kosmas E, Bratis D, Moussas G, Tzanakis N.

Neuropsychiatr Dis Treat. 2016 Feb 9;12:297-328. doi: 10.2147/NDT.S79354. eCollection 2016. Review.

15.

Psychological and personality factors in type 2 diabetes mellitus, presenting the rationale and exploratory results from The Maastricht Study, a population-based cohort study.

van Dooren FE, Denollet J, Verhey FR, Stehouwer CD, Sep SJ, Henry RM, Kremers SP, Dagnelie PC, Schaper NC, van der Kallen CJ, Koster A, Pouwer F, Schram MT.

BMC Psychiatry. 2016 Jan 27;16:17. doi: 10.1186/s12888-016-0722-z.

16.

Impact of White Matter Lesions on Depression in the Patients with Alzheimer's Disease.

Lee JJ, Lee EY, Lee SB, Park JH, Kim TH, Jeong HG, Kim JH, Han JW, Kim KW.

Psychiatry Investig. 2015 Oct;12(4):516-22. doi: 10.4306/pi.2015.12.4.516. Epub 2015 Sep 30.

17.

Associations between arterial stiffness, depressive symptoms and cerebral small vessel disease: cross-sectional findings from the AGES-Reykjavik Study.

van Sloten TT, Mitchell GF, Sigurdsson S, van Buchem MA, Jonsson PV, Garcia ME, Harris TB, Henry RM, Levey AS, Stehouwer CD, Gudnason V, Launer LJ.

J Psychiatry Neurosci. 2016 Apr;41(3):162-8.

18.

Depressive symptoms related to low fractional anisotropy of white matter underlying the right ventral anterior cingulate in older adults with atherosclerotic vascular disease.

Bijanki KR, Matsui JT, Mayberg HS, Magnotta VA, Arndt S, Johnson HJ, Nopoulos P, Paradiso S, McCormick LM, Fiedorowicz JG, Epping EA, Moser DJ.

Front Hum Neurosci. 2015 Jul 15;9:408. doi: 10.3389/fnhum.2015.00408. eCollection 2015.

19.

Elevated circulating vascular cell Adhesion Molecule-1 (sVCAM-1) is associated with concurrent depressive symptoms and cerebral white matter Hyperintensities in older adults.

Tchalla AE, Wellenius GA, Sorond FA, Travison TG, Dantoine T, Lipsitz LA.

BMC Geriatr. 2015 Jun 4;15:62. doi: 10.1186/s12877-015-0063-7.

20.

Can we clinically recognize a vascular depression? The role of personality in an expanded threshold model.

Turk BR, Gschwandtner ME, Mauerhofer M, Löffler-Stastka H.

Medicine (Baltimore). 2015 May;94(18):e743. doi: 10.1097/MD.0000000000000743.

Supplemental Content

Support Center